Pediatric Hereditary Hemorrhagic Telangiectasia (HHT) or Osler-Weber-Rendu Syndrome

Hereditary Hemorrhagic Telangiectasia (HHT) or Osler-Weber-Rendu Syndrome is a complicated genetic circulatory condition that can affect many organs. Children’s Health℠ in partnership with UT Southwestern, an HHT Center of Excellence, offers the only pediatric HHT program in North Texas and the region.

What is Pediatric Hereditary Hemorrhagic Telangiectasia (HHT) or Osler-Weber-Rendu Syndrome?

Hereditary hemorrhagic telangiectasia (HHT) affects blood vessels and can lead to bleeding when abnormally structured blood vessels rupture. It’s also known as Osler-Weber-Rendu syndrome. 

HHT can affect many organs. However, the first sign is often unpredictable, severe nosebleeds. 

Normally, blood circulates from the heart to arteries and then to smaller vessels called arterioles and capillaries. From there, the blood should move to veins and then return to the heart. For people with HHT, some blood flows directly to the veins from the arteries.  As a result, higher blood pressure builds up in veins, which have thinner and less elastic walls and can burst. This bleeding is known as hemorrhaging. 

When capillaries burst in smaller vessels near the skin or inside the nose, the condition is called telangiectases (singular telangiectasia). This looks like red or purple pin pricks on the skin. 

Arteriovenous malformations (AVMs) are large vascular malformations that can occur elsewhere in the body, including the lungs, liver, brain and spine. Serious problems can occur from AVMs in these organs. AVMs in the brain can cause critical, life-threatening complications. AVMs in the lungs can cause blood oxygen levels to be low.

What are the different types of Pediatric Hereditary Hemorrhagic Telangiectasia (HHT) or Osler-Weber-Rendu Syndrome?

There are three types of hereditary hemorrhagic telangiectasia. They are differentiated primarily by the genetic cause, signs and symptoms.

Type 1

  • Symptoms develop earlier
  • Higher risk of blood vessel malformation in lungs and brain
  • Women are at a higher risk for type 1

What are the causes of Pediatric Hereditary Hemorrhagic Telangiectasia (HHT) or Osler-Weber-Rendu Syndrome?

HHT is an autosomal dominant genetic disorder. If a parent has HHT, his or her children have a 50 percent chance of being diagnosed with it

Frequently Asked Questions

  • Can HHT be cured?

    No cure exists, but treatment and appropriate screening can help a patient avoid serious complications.

  • How common is HHT?

    HHT affects approximately one in 6,000 people in the U.S. By comparison, cystic fibrosis occurs in roughly one in 2,500 live births. Both men and women can be affected by HHT, and approximately half the children of an adult with HHT will also inherit the condition. 

  • Will a child with HHT be able to live a normal life?

    The good news is that in most cases, HHT isn't life-threatening as long as symptoms are managed effectively.